Swine flu: GlaxoSmithKline will donate 50 million vaccine doses to poor nations

Filed under: Healthcare , GlaxoSmithKline , Novartis The United States may worry about having enough H1N1 vaccine to protect its population from swine flu, but at least it’s getting precious doses. Many developing countries, which can’t afford the sometimes expensive medication, don’t have any at all. That may change soon. The United Kingdom’s GlaxoSmithKline ( GSK ) said Tuesday it will donate 50 million doses of its adjuvanted H1N1 influenza vaccine to developing countries most in need through the World Health Organization. Initial shipments will start by the end of November with shipments to be completed by May 2010, the WHO said. GlaxoSmithKline’s move comes as several other pharmaceuticals have pledged similar measures. Continue reading Swine flu: GlaxoSmithKline will donate 50 million vaccine doses to poor nations Swine flu: GlaxoSmithKline will donate 50 million vaccine doses to poor nations originally appeared on DailyFinance on Wed, 11 Nov 2009 10:30:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments

Read the original:
Swine flu: GlaxoSmithKline will donate 50 million vaccine doses to poor nations

Tagged with: a-friend-via • entry • novartis • organization- • population-from • swine flu • united-states- • vaccine • with-shipments • world • world health organization

Filed under: Business News

Like this post? Subscribe to my RSS feed and get loads more!